The Swiss pharmaceutical company reiterated its outlook, predicting single-digit growth this year, following an end to the slump in COVID-19-related sales.
Roche prepares for business after boom from COVID-related products
Read Next
- Harnessing AI for Neuroscience: IIT Madras and NVIDIA’s Innovative Approach
- International Criminal Court issues arrest warrants for Netanyahu and Hamas officials
- RBI purchases $9.6 billion in September to curb rupee’s appreciation amid Fed rate cut buzz, ET BFSI
- Asian Development Bank to provide $4.25 billion to Tata Power for clean energy power projects, ET BFSI
- SEC charges Touzi Capital in connection with $115M securities offering fraud
- NVIDIA Reports Record Q3 Revenue Amid AI Demand Surge
- Regulations prompt CFOs to boost cyber investments, majority to spike cybersecurity budget, ET BFSI
